It was found that in the carton of Taromentin 1000 mg + 200 mg (batch 2010525) there was a vial of Taromentin 500 mg + 100 mg, containing half the dose of active substances, which may lead to insufficient therapeutic efficacy. Potential effects: lack of treatment efficacy, possible infection-related complications.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
FAQ